NCT06696274Recruiting
Kinesiophobia, Pain, Balance, Quality of Life and Mental Status in Hemodialysis Patients
Investigation of the Relationship Between Kinesiophobia and Pain, Balance, Quality of Life and Mental Status in Hemodialysis Patients
Source: ClinicalTrials.gov · Last updated 25 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of our study was to investigate the relationship between kinesiophobia and pain, balance, physical performance, quality of life and mental status in patients receiving hemodialysis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 32 (estimated)
- First submitted
- 6 Nov 2024
- Start date
- 18 Nov 2024
- Primary completion date
- Sept 2025
- Lead sponsor
- Kirsehir Ahi Evran Universitesi
- Diseases
- Chronic kidney disease
- NCT number
- NCT06696274
What you commit to
- Study type: Observational
- Planned participants: 32
- From 18 Nov 2024 to the primary completion date, Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- -Having musculoskeletal disorders that may affect physical performance
Who the study is looking for
- Patients with end stage renal disease receiving hemodialysis
- Receiving hemodialysis for more than 3 months
- Being clinically stable
- Volunteering to participate in this stud
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kirsehir Ahi Evran University Coordinator of this site? Confirm its status | Kırşehir | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.